T

TriSalus Life Sciences Inc
NASDAQ:TLSI

Watchlist Manager
TriSalus Life Sciences Inc
NASDAQ:TLSI
Watchlist
Price: 4.57 USD -0.65% Market Closed
Market Cap: 172.9m USD

Intrinsic Value

The intrinsic value of one TLSI stock under the Base Case scenario is 6.76 USD. Compared to the current market price of 4.57 USD, TriSalus Life Sciences Inc is Undervalued by 32%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

TLSI Intrinsic Value
6.76 USD
Undervaluation 32%
Intrinsic Value
Price
T
Base Case Scenario

Valuation History
TriSalus Life Sciences Inc

What is Valuation History?
Compare TLSI to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about TLSI?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about TriSalus Life Sciences Inc
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
TriSalus Life Sciences Inc

Current Assets 25.1m
Cash & Short-Term Investments 13m
Receivables 5.5m
Other Current Assets 6.6m
Non-Current Assets 3.5m
PP&E 3.1m
Other Non-Current Assets 424k
Efficiency

Free Cash Flow Analysis
TriSalus Life Sciences Inc

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
TriSalus Life Sciences Inc

Revenue
38.6m USD
Cost of Revenue
-5.6m USD
Gross Profit
33m USD
Operating Expenses
-76.5m USD
Operating Income
-43.5m USD
Other Expenses
-826k USD
Net Income
-44.3m USD
Fundamental Scores

TLSI Profitability Score
Profitability Due Diligence

TriSalus Life Sciences Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Exceptional 3Y Average ROE
Exceptional ROE
ROE is Increasing
Exceptional Gross Margin
41/100
Profitability
Score

TriSalus Life Sciences Inc's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

TLSI Solvency Score
Solvency Due Diligence

TriSalus Life Sciences Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Low D/E
Short-Term Solvency
Positive Net Debt
Long-Term Solvency
45/100
Solvency
Score

TriSalus Life Sciences Inc's solvency score is 45/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

TLSI Price Targets Summary
TriSalus Life Sciences Inc

Wall Street analysts forecast TLSI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for TLSI is 11.54 USD with a low forecast of 9.09 USD and a high forecast of 16.8 USD.

Lowest
Price Target
9.09 USD
99% Upside
Average
Price Target
11.54 USD
152% Upside
Highest
Price Target
16.8 USD
268% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

TriSalus Life Sciences Inc
does not pay dividends
Shareholder Yield

Current shareholder yield for TLSI is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

TLSI Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one TLSI stock?

The intrinsic value of one TLSI stock under the Base Case scenario is 6.76 USD.

Is TLSI stock undervalued or overvalued?

Compared to the current market price of 4.57 USD, TriSalus Life Sciences Inc is Undervalued by 32%.

Back to Top